WideScreen™ Biomarker Assay Kits WideScreen™ Biomarker Assay Kits are the result of an ongoing collaboration between Novagen® and Rules Based Medicine (RBM). A portfolio of products for the Luminex® xMAP® System has been developed containing specific multiplex panel kits that utilize assays validated and used in the HumanMAP® and RodentMAP® service portfolio from RBM. Panels focus on specific therapeutic areas or disease states and allow data generated in discovery and preclinical stages to be correlated to data from later phases of drug development.
Key biomarkers for each panel are known to be involved directly or indirectly in a disease process. WideScreen Biomarker Assay Kits are developed for the emerging needs of scientists and address the key biomarker requirements of relevance, validation,
and quality.
- Proven gold standard multiplex assays used by leading pharma and biotech companies worldwide to provide valuable insight into the development of new drugs and proof of concept clinical studies.
- Extensive validation in a CLIA laboratory using the NCCLS quality standards ensures the ability to generate the highest quality data possible to maximize the knowledge gained from precious, often limited, biological samples.
|
